The mRNA level of CharcotLeyden crystal protein/galectin-10 is a marker for CRTH2 activation in human whole blood in vitro

Biomarkers

Volumn 15, Issue 7, 2010, Pages 646-654

  Lin, Tai An ^a   Kourteva, Galina ^a   Hilton, Holly ^a   Li, Hongli ^a   Tare, Nadine S ^a   Carvajal, Valerie ^a   Hang, Julie S ^a   Wei, Xin ^a   Renzetti, Louis M ^a  

^a HOFFMANN LA ROCHE INC   (United States)

Author keywords

Allergic diseases; Basophils; Eosinophils; Microarray; Prostaglandin D2; Th2 cells

Indexed keywords

CAY10471; GALECTIN; MESSENGER RNA; PROSTAGLANDIN RECEPTOR BLOCKING AGENT; PROTEIN CRTH2; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; GLYCOPROTEIN; IMMUNOGLOBULIN RECEPTOR; LYSOPHOSPHOLIPASE; PRIMER DNA; PROSTAGLANDIN D2 RECEPTOR; PROSTAGLANDIN RECEPTOR;

ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; IN VITRO STUDY; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; REAL TIME POLYMERASE CHAIN REACTION; BLOOD; DNA MICROARRAY; GENETICS; METABOLISM; POLYMERASE CHAIN REACTION;

BASE SEQUENCE; BIOLOGICAL MARKERS; DNA PRIMERS; GLYCOPROTEINS; HUMANS; LYSOPHOSPHOLIPASE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMERASE CHAIN REACTION; RECEPTORS, IMMUNOLOGIC; RECEPTORS, PROSTAGLANDIN; RNA, MESSENGER;

EID: 77958616272     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.3109/1354750X.2010.511266     Document Type: Article

References (42)

1. Ackerman SJ, Corrette SE, Rosenberg HF, Bennett JC, Mastrianni DM, Nicholson-Weller A, Weller PF, Chin DT, Thenen DG. (1993). Molecular cloning and characterization of human eosinophil Charcot-Leyden crystal protein (lysophospholipase). Similarities to IgE binding proteins and the S-type animal lectin superfamily. J Immunol 150:456-68. (Pubitemid 23133621)
2. Ackerman SJ, Liu L, Kwatia MA, Savage MP, Leonidas DD, Swaminathan GJ, Acharya KR. (2002). Charcot-Leyden crystal protein (galectin-10) is not a dual function galectin with lyso-phospholipase activity but binds a lysophospholipase inhibitor in a novel structural fashion. J BiolChem 277:14859-68. (Pubitemid 34952559)
3. Ackerman SJ, Loegering DA, Gleich GJ. (1980). The human eosinophil Charcot-Leyden crystal protein: biochemical characteristics and measurement by radioimmunoassay. J Immunol 125:2118-26.
4. Ackerman SJ, Weil GJ, Gleich GJ. (1982). Formation of Charcot-Leyden crystals by human basophils. J Exp Med 155:1597-609.
5. Archer GT, Blackwood A. (1965). Formation of Charcot-Leyden crystals in human eosinophils and basophils and study of the composition of isolated crystals. J Exp Med 122:173-80.
6. Armer RE, Ashton MR, Boyd EA, Brennan CJ, Brookfeld FA, Gazi L, Gyles SL, Hay PA, Hunter MG, Middlemiss D, Whittaker M, Xue L, Pettipher R. (2005). Indole-3-acetic acid antagonists of the pros-taglandin D2 receptor CRTH2. J Med Chem 48:6174-7. (Pubitemid 41428972)
7. Breyer RM, Bagdassarian CK, Myers SA, Breyer MD. (2001). Prostanoid receptors: subtypes and signaling. Annu Rev PharmacolToxicol 41:661-90.
8. Bryan SA, Jose PJ, Topping JR, Wilhelm R, Soderberg C, Kertesz D, Barnes PJ, Williams TJ, Hansel TT, Sabroe I. (2002). Responses of leukocytes to chemokines in whole blood and their antagonism by novel CC-chemokine receptor 3 antagonists. Am J RespirCrit Care Med 165:1602-9. (Pubitemid 34693939)
9. Bryborn M, Hallden C, Sall T, Cardell LO. (2010). CLC-a novel susceptibility gene for allergic rhinitis? Allergy 65:220-8.
10. Camby I, Le Mercier M, Lefranc F, Kiss R. (2006). Galectin-1: a small protein with major functions. Glycobiology 16:137R-57R. (Pubitemid 44530693)
11. Devouassoux G, Pachot A, Laforest L, Diasparra J, Freymond N, Van Ganse E, Mougin B, Pacheco Y. (2008). Galectin-10 mRNA is overexpressed in peripheral blood of aspirin-induced asthma. Allergy 63:125-31. (Pubitemid 350198244)
12. Dor PJ, Ackerman SJ,Gleich GJ. (1984). Charcot-Leyden crystal protein and eosinophil granule major basic protein in sputum of patients with respiratory diseases. Am Rev Respir Dis 130:1072-7.
13. Fujishima H, Fukagawa K, Okada N, Takano Y, Tsubota K, Hirai H, Nagata K, Matsumoto K, Saito H. (2005). Prostaglandin D2 induces chemotaxis in eosinophils via its receptor CRTH2 and eosinophils may cause severe ocular infammation in patients with allergic conjunctivitis. Cornea 24:S66-70. (Pubitemid 41688559)
14. Ge XN, Bahaie NS, Kang BN, Hosseinkhani MR, Ha SG, Frenzel EM, Liu FT, Rao SP, Sriramarao P. (2010). Allergen-induced airway remodeling is impaired in galectin-3-defcient mice. J Immunol 185:1205-14.
15. Ghafouri B, Irander K, Lindbom J, Tagesson C,Lindahl M. (2006). Comparative proteomics of nasal fuid in seasonal allergic rhinitis. J Proteome Res 5:330-8. (Pubitemid 43222301)
16. Hata AN, Breyer RM. (2004). Pharmacology and signaling of prostaglandin receptors: multiple roles in infammation and immune modulation. PharmacolTher 103:147-66.
17. Hirai H, Tanaka K, Yoshie O, Ogawa K, Kenmotsu K, Takamori Y, Ichimasa M, Sugamura K, Nakamura M, Takano S, Nagata K. (2001). Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-trans-membrane receptor CRTH2. J Exp Med 193:255-61. (Pubitemid 32524457)
18. Huang JL, Gao PS, Mathias RA, Yao TC, Chen LC, Kuo ML, Hsu SC, Plunkett B, Togias A, Barnes KC, Stellato C, Beaty TH, Huang SK. (2004). Sequence variants of the gene encoding chemoattract-ant receptor expressed on T2 cells (CRTH2) are associated with asthma and diferentially infuence mRNA stability. Hum Mol Genet 13:2691-7. (Pubitemid 39485417)
19. Kostenis E, Ulven T. (2006). Emerging roles of DP and CRTH2 in allergic infammation. Trends Mol Med 12:148-58.
20. Kubach J, Lutter P, Bopp T, Stoll S, Becker C, Huter E, Richter C, Weingarten P, Warger T, Knop J, Mullner S, Wijdenes J, Schild H, Schmitt E, Jonuleit H. (2007). Human CD4+CD25+ regulatory T cells: proteome analysis identifes galectin-10 as a novel marker essential for their anergy and suppressive function. Blood 110:1550-8. (Pubitemid 47443971)
21. Luster AD, Tager AM. (2004). T-cell trafcking in asthma: lipid mediators grease the way. Nat Rev Immunol 4:711-24.
22. Martin LM, Peebles RS. (2006). Update on the role of prostaglandins in allergic lung infammation: separating friends from foes, harder than you might think. J Allergy Clin Immunol 117:1036-9.
23. Mathiesen JM, Christopoulos A, Ulven T, Royer JF, Campillo M, Heinemann A, Pardo L, Kostenis E. (2006). On the mechanism of interaction of potent surmountable and insurmountable antagonists with the prostaglandin D2 receptor CRTH2. MolPharmacol 69:1441-53.
24. Matsuoka T, Hirata M, Tanaka H, Takahashi Y, Murata T, Kabashima K, Sugimoto Y, Kobayashi T, Ushikubi F, Aze Y, Eguchi N, Urade Y, Yoshida N, Kimura K, Mizoguchi A, Honda Y, Nagai H, Narumiya S. (2000). Prostaglandin D2 as a mediator of allergic asthma. Science 287:2013-17.
25. Monneret G, Gravel S, Diamond M, Rokach J, Powell WS. (2001). Prostaglandin D2 is a potent chemoattractant for human eosinophils that acts via a novel DP receptor. Blood 98:1942-8.
26. Nagata K, Hirai H. (2003). The second PGD(2) receptor CRTH2: structure, properties, and functions in leukocytes. Prostaglandins LeukotEssent Fatty Acids 69:169-77. (Pubitemid 36976172)
27. Nagata K, Tanaka K, Ogawa K, Kemmotsu K, Imai T, Yoshie O, Abe H, Tada K, Nakamura M, Sugamura K, Takano S. (1999). Selective expression of a novel surface molecule by human T2 cells in vivo. J Immunol 162:1278-86. (Pubitemid 29306996)
28. Powell WS. (2003). A novel PGD(2) receptor expressed in eosinophils. Prostaglandins LeukotEssent Fatty Acids 69:179-85.
29. Sandham DA, Adcock C, Bala K, Barker L, Brown Z, Dubois G, Budd D, Cox B, Fairhurst RA, Furegati M, Leblanc C, Manini J, Proft R, Reilly J, Stringer R, Schmidt A, Turner KL, Watson SJ, Willis J, Williams G, Wilson C. (2009). 7-Azaindole-3-acetic acid derivatives: potent and selective CRT2 receptor antagonists. Bioorg Med ChemLett 19:4794-8.
30. Sandham DA, Aldcroft C, Baettig U, Barker L, Beer D, Bhalay G, Brown Z, Dubois G, Budd D, Bidlake L, Campbell E, Cox B, Everatt B, Harrison D, Leblanc CJ, Manini J, Proft R, Stringer R, Tompson KS, Turner KL, Tweed MF, Walker C, Watson SJ, Whitebread S, Willis J, Williams G, Wilson C. (2007). 2-Cycloalkyl phenoxyacetic acid CRT2 receptor antagonists. Bioorg Med ChemLett 17:4347-50. (Pubitemid 47021382)
31. Sandig H, Pease JE, Sabroe I. (2007). Contrary prostaglandins: the opposing roles of PGD2 and its metabolites in leukocyte function. J LeukocBiol 81:372-82. (Pubitemid 46198387)
32. Satoh T, Moroi R, Aritake K, Urade Y, Kanai Y, Sumi K, Yokozeki H, Hirai H, Nagata K, Hara T, Utsuyama M, Hirokawa K, Sugamura K, Nishioka K, Nakamura M. (2006). Prostaglandin D2 plays an essential role in chronic allergic infammation of the skin via CRTH2 receptor. J Immunol 177:2621-9. (Pubitemid 44201021)
33. Sawyer N, Cauchon E, Chateauneuf A, Cruz RP, Nicholson DW, Metters KM, O'Neill GP, Gervais FG. (2002). Molecular pharmacology of the human prostaglandin D2 receptor, CRTH2. Br J Pharmacol 137:1163-72. (Pubitemid 36071733)
34. Schratl P, Royer J F, Kostenis E, Ulven T, Sturm EM, Waldhoer M, Hoefer G, Schuligoi R, Lippe IT, Peskar BA, Heinemann A. (2007). The role of the prostaglandin D2 receptor, DP, in eosi-nophil trafcking. J Immunol 179:4792-9.
35. Shiraishi Y, Asano K, Nakajima T, Oguma T, Suzuki Y, Shiomi T, Sayama K, Niimi K, Wakaki M, Kagyo J, Ikeda E, Hirai H, Yamaguchi K and Ishizaka A. (2005). Prostaglandin D2-induced eosinophilic airway infammation is mediated by CRTH2 receptor. J PharmacolExpTher, 312: 954-60. (Pubitemid 40293753)
36. Shirasaki H, Kikuchi M, Kanaizumi E, Himi T. (2009). Accumulation of CRTH2-positive leukocytes in human allergic nasal mucosa. Ann Allergy Asthma Immunol, 102: 110-5.
37. Swaminathan GJ, Leonidas DD, Savage MP, Ackerman SJ, Acharya KR. (1999). Selective recognition of mannose by the human eosi-nophil Charcot-Leyden crystal protein (galectin-10): a crystal-lographic study at 1.8 a resolution. Biochemistry 38:15406.
38. Tanaka K, Hirai H, Takano S, Nakamura M, Nagata K. (2004). Efects of prostaglandin D2 on helper T cell functions. BiochemBiophys Res Commun 316:1009-14. (Pubitemid 38369053)
39. Torres D, Paget C, Fontaine J, Mallevaey T, Matsuoka T, Maruyama T, Narumiya S, Capron M, Gosset P, Faveeuw C, Trottein F. (2008). Prostaglandin D2 inhibits the production of IFN-gamma by invariant NK T cells: consequences in the control of B16 melanoma. J Immunol 180:783-92.
40. Ulven T, Kostenis E. (2005). Minor structural modifcations converts the dual TP/CRTH2 antagonist ramatroban into a highly selective and potent CRTH2 antagonist. J Med Chem 48:897-900. (Pubitemid 40270433)
41. Wang J, Xu Y, Zhao H, Sui H, Liang H, Jiang X. (2009). Genetic variations in chemoattractant receptor expressed on T2 cells (CRTH2) is associated with asthma susceptibility in Chinese children. MolBiol Rep 36:1549-53.
42. Xue L, Gyles SL, Wettey FR, Gazi L, Townsend E, Hunter MG, Pettipher R. (2005). Prostaglandin D2 causes preferential induction of proinfammatory T2 cytokine production through an action on chemoattractant receptor-like molecule expressed on T2 cells. J Immunol 175:6531-6. (Pubitemid 41598895)